Search Results
Jun 01, 2026, 04:19 ET Sobi to present new data on pegcetacoplan at ERA 2026
IC-MPGN. It is the largest single trial conducted in these populations and the only study to include adolescent and adult patients, with native and post-transplant kidneys. Study participants were randomised to receive 1080 mg of pegcetacoplan or placebo twice weekly for 26 weeks. Following this 26-week
More news about: Swedish Orphan Biotrauma AB
Jun 01, 2026, 03:05 ET MSA Safety Debuts Next-Generation Firefighter Technologies at Interschutz 2026
creates a local wireless network on scene, and can transmit data to cloud–based systems when internet connectivity is available for remote monitoring and post–incident analysis.MSA Repeater: Extends radio connectivity in challenging environments, such as high–rise buildings, basements, tunnels,
More news about: MSA Safety
Jun 01, 2026, 03:05 ET MSA Safety présente les technologies de nouvelle génération pour les pompiers à l'occasion du salon Interschutz 2026
transmettre des données à des systèmes basés sur le nuage lorsque la connectivité Internet est disponible pour la surveillance à distance et l'analyse post-incident.Répéteur MSA : étend la connectivité radio dans les environnements difficiles, tels que les immeubles de grande hauteur, les sous-sols,
More news about: MSA Safety
Jun 01, 2026, 03:04 ET China's Original Innovative Drug Cipepofol Approved for Marketing by the U.S. FDA
2023;8.3(IF).Liu YJ, Zuo LY, Li XY, et al. Early sedation using ciprofol for intensive care unit patients requiring mechanical ventilation: a pooled post-hoc analysis of data from phase 2 and phase 3 trials. Ann Intensive Care. 2024;7.8(IF).Qin LL, Ren L, Wan SL, et al. Design, synthesis, and
More news about: Haisco
Jun 01, 2026, 03:00 ET Petal Ads Unveils Full-Scenario Smart Culture and Tourism Marketing Solution at ITB China 2026
experience zone demonstrated how HarmonyOS technologies can enhance travel experiences. It mapped out the entire user journey – from inspiration to post-trip sharing – making every trip smoother and more engaging.Within the HarmonyOS culture and tourism ecosystem, full-scenario media and multi-device
More news about: Huawei Consumer Business Group
Jun 01, 2026, 02:20 ET JA Solar Leads the Post‑Cycle PV Market with Dual‑Technology Breakthroughs and Integrated Solutions
BEIJING, June 1, 2026 /PRNewswire/ -- JA Solar recently outlined its strategic roadmap for the post‑cycle photovoltaic (PV) market, reaffirming its leadership across TOPCon and BC technologies while advancing toward a fully integrated energy‑solutions
More news about: JA Solar Technology Co., Ltd.
Jun 01, 2026, 01:25 ET JA Solar Leads the Post‑Cycle PV Market with Dual‑Technology Breakthroughs and Integrated Solutions
BEIJING, June 1, 2026 /PRNewswire/ -- JA Solar recently outlined its strategic roadmap for the post‑cycle photovoltaic (PV) market, reaffirming its leadership across TOPCon and BC technologies while advancing toward a fully integrated energy‑solutions
More news about: JA Solar Technology Co., Ltd.
Jun 01, 2026, 00:05 ET HONEYWELL UNVEILS NEW BRANDS EFFECTIVE POST SPIN-OFF: HONEYWELL TECHNOLOGIES AND HONEYWELL AEROSPACE
multimedia:https://www.prnewswire.com/news-releases/honeywell-unveils-new-brands-effective-post-spin-off-honeywell-technologies-and-honeywell-aerospace-302786578.htmlSOURCE
More news about: Honeywell
May 31, 2026, 23:51 ET Aphranel® MagiCCrystal CaHA Filler obtient la certification MDR de l'UE en tant qu'injectable régénérateur de première qualité
européenne en matière de gestion de la qualité, d'évaluation clinique, de normes de fabrication, de sécurité, de traçabilité et de surveillance post-commercialisation.Entré en vigueur en mai 2021, le règlement européen sur les dispositifs médicaux (MDR) a remplacé l'ancienne directive sur les dispositifs
More news about: SHANGHAI MOYOM BIOTECHNOLOGY CO., LTD; Aphranel
May 31, 2026, 20:15 ET ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and Delivering Strong Proof-of-Concept
*Note: Efficacy analyses were performed only in patients who received at least one post‑baseline tumor assessment. The number of such patients is less than or equal to the total number of patients enrolled in the group.(2)
More news about: CStone Pharmaceuticals
May 31, 2026, 20:00 ET 2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein), Showing Robust Survival Benefits in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
chemotherapy and immunotherapy have not yet delivered satisfactory outcomes. Therefore, there remains a substantial and urgent unmet medical need in the post-immunotherapy setting for NSCLC.As a PD-1/IL-2α-bias bispecific molecule, IBI363 has demonstrated encouraging clinical benefit in
More news about: Innovent Biologics
May 31, 2026, 08:27 ET Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
(ILD)/Pneumonitis — Fatal and life-threatening interstitial lung disease (ILD) or pneumonitis can occur in patients treated with ERLEADA.Post-marketing cases of ILD/pneumonitis, including fatal cases, occurred in patients treated with ERLEADA. Across clinical trials (TITAN and SPARTAN, n=1327),
More news about: Johnson & Johnson
May 31, 2026, 08:01 ET Lilly's Retevmo (selpercatinib) demonstrated an 83% reduction in the risk of disease recurrence or death as adjuvant therapy for people with early-stage RET fusion-positive lung cancer
included fever, rash and arthralgias or myalgias with concurrent decreased platelets or transaminitis. Stevens-Johnson Syndrome has been observed in the post-marketing setting. Discontinue Retevmo in patients with Stevens-Johnson Syndrome. If hypersensitivity occurs, withhold Retevmo and begin corticosteroids
More news about: Eli Lilly and Company
May 31, 2026, 08:00 ET Miami Retirement Summit 2026 Returns to The Biltmore Featuring Coral Gables Mayor Vince Lago
opportunities to connect with fellow South Florida residents preparing for retirement. VIP attendees will receive preferred seating and access to a private post-event experience following the summit.Ticket proceeds will benefit St. Jude Children's Research Hospital, supporting its mission of advancing
More news about: Guerra Wealth Advisors
May 31, 2026, 00:13 ET Huawei è stata riconosciuta come Leader nel Gartner® Magic Quadrant™ 2026 dedicato alle infrastrutture LAN aziendali cablate e wireless per il quarto anno consecutivo
rischio di intercettazione dei pacchetti a livello fisico. Inoltre, la sicurezza end-to-end basata su MACsec, combinata con la crittografia post-quantistica (Post-Quantum Cryptography, PQC), garantisce una protezione a lungo termine della trasmissione dei dati anche con l'evoluzione del calcolo computazionale
More news about: Huawei
May 31, 2026, 00:05 ET Huawei voor het vierde jaar op rij benoemd tot leider in het Gartner® Magic Quadrant™ 2026 voor Enterprise Wired- en Wireless LAN-infrastructuur
Wi-Fi Shield-technologie elimineert het risico van afluisteren van pakketten op de fysieke laag. Bovendien biedt end-to-end MACsec in combinatie met post-kwantumcryptografie (PQC) langdurige beveiliging voor gegevensoverdracht, zelfs naarmate kwantumcomputers zich verder ontwikkelen.Ruimtelijke
More news about: Huawei
May 30, 2026, 14:30 ET Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
and lower respiratory tract caused by chronic HPV 6 or HPV 11 infection. RRP can lead to severe voice disturbance, compromised airways, and recurrent post-obstructive pneumonia. Although rare, RRP has the potential for transformation to malignant cancer and can be fatal. Management of RRP has primarily
More news about: Precigen, Inc.
May 30, 2026, 08:05 ET ROADS Phase 3 Clinical Trial Data Presented at ASCO26 Show GammaTile® Provides Superior Tumor Control Leading to Patients Living Longer Without Recurrence Compared to Standard of Care in Newly Diagnosed Operable Brain Metastases
radiation regimens remains a persistent challenge: published data show that approximately 20% of patients do not complete their full prescribed course of post-operative radiation therapy.4,5"GT Medical was founded to address unmet treatment needs for patients with operable brain tumors,"
More news about: GT Medical Technologies
May 30, 2026, 04:14 ET Replenish Nutrients: Market Has Yet to Price in the H2 2026 Capacity and Licensing Inflection
last quiet quarter before the inflection.Legal DisclaimerThis post is based upon reliable sources, namely regulated press releases from the company and investor presentations. Nevertheless, this post may contain interpretations, estimates, or opinions of the authors, or other non-factual
More news about: Replenish Nutrients
May 29, 2026, 18:31 ET MD Hyperbaric expands national footprint to Texas, Nevada and New York
cellular level.Patients seek HBOT for a wide range of conditions, including:Wound healing and post-surgical recoverySudden hearing lossPost-radiation therapySports injuries and athletic performance optimizationChronic pain and inflammationConcussions
More news about: MD Hyperbaric
May 29, 2026, 17:00 ET Colorado State University Global Commencement Features Two Emmy-Award Winning Speakers
service, growth, relationships, and the ability to positively influence the people around you."Ibarra and his fellow graduates, many of whom are post-traditional learners –adults, parents, first-generation students, or military service members seeking new skills for their workplace success– walked
More news about: Colorado State University Global
May 29, 2026, 14:51 ET University of Phoenix Launches Phoenix Veterans and Affiliates Network (PVAN) to Support Military-Connected Students and Alumni
development, storytelling, and peer-to-peer support while connecting participants to institutional and career resources that enhance persistence and pursuit of post-graduation success. The organization officially launches during the University's
More news about: University of Phoenix
May 29, 2026, 14:00 ET RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
Geater SL, et al. Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6. Lancet Oncol. 2015;16(7):830-838. doi:10.1016/S1470-2045(15)00026-1 7
More news about: Johnson & Johnson
May 29, 2026, 13:30 ET Why More Women Are Comparing the Long-Term Cost of Shaving, Waxing, and Laser Hair Removal
Breaking Down the True Cost of Each MethodShaving appears affordable on the surface, but razor cartridges, shaving cream, exfoliants, and post-shave moisturizers can create a recurring annual expense. While the cost may remain relatively low compared with professional services, it continues
More news about: Laser by Aleya
May 29, 2026, 12:16 ET OCI Global Q1 2026 Trading Update
equity consideration, offset by ongoing HoldCo costs, including one-offs and operational cash flows, as well as the elimination of OCI AH net cash post-divestment. As of the 29 May 2026, the Group had a net cash position of approximately USD 1.08 billion.Key Strategic and Business Highlights
More news about: OCI Global